Limited-stage DLBCL: it’s patient selection

بواسطة Persky, Daniel O.
الحاوية / القاعدة Blood (2018)

Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy

بواسطة Islam, Shariful, Espitia, Claudia M., Persky, Daniel O., Carew, Jennifer S., Nawrocki, Steffan T.
الحاوية / القاعدة Blood Adv (2020)

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma

بواسطة Islam, Shariful, Espitia, Claudia M., Persky, Daniel O., Carew, Jennifer S., Nawrocki, Steffan T.
الحاوية / القاعدة Viruses (2021)

Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI

بواسطة Akhenblit, Paul J., Hanke, Neale T., Gill, Alexander, Persky, Daniel O., Howison, Christine M., Pagel, Mark D., Baker, Amanda F.
الحاوية / القاعدة Mol Imaging (2016)

Alisertib (MLN8237) an Investigational Agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines suppo...

بواسطة Qi, Wenqing, Spier, Catherine, Liu, Xiaobing, Agarwal, Amit, Cooke, Laurence S., Persky, Daniel O, Chen, Deyu, Miller, Thomas P., Mahadevan, Daruka
منشور في 2012

Aurora Inhibitor MLN8237 in Combination with Docetaxel Enhances Apoptosis and Antitumor Activity in Mantle Cell Lymphoma

بواسطة Qi, Wenqing, Cooke, Laurence S., Liu, Xiaobing, Rimsza, Lisa, Roe, Denise J., Manziolli, Ann, Persky, Daniel O., Miller, Thomas P., Mahadevan, Daruka
منشور في 2011

Aurora A inhibitor (MLN8237) plus Vincristine plus Rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

بواسطة Mahadevan, Daruka, Stejskal, Amy, Cooke, Laurence S., Manziello, Ann, Morales, Carla, Persky, Daniel O., Fisher, Richard I., Miller, Thomas P., Qi, Wenqing
الحاوية / القاعدة Clin Cancer Res (2012)

Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2

بواسطة Mahadevan, Daruka, Morales, Carla, Cooke, Laurence S., Manziello, Ann, Mount, David W., Persky, Daniel O., Fisher, Richard I., Miller, Thomas P., Qi, Wenqing
منشور في 2014

A Phase II Trial of Single Agent Bevacizumab in Patients with Relapsed, Aggressive Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0108

بواسطة Stopeck, Alison T., Unger, Joseph, Rimsza, Lisa M., Bellamy, William T., Iannone, Maria, Persky, Daniel O., LeBlanc, Michael, Fisher, Richard I., Miller, Thomas P.
منشور في 2009

Synergistic Induction of Apoptosis in High-Risk DLBCL by BCL2 Inhibition with ABT-199 Combined With Pharmacologic Loss of MCL1

بواسطة Li, Lingxiao, Pongtornpipat, Praechompoo, Tiutan, Timothy, Kendrick, Samantha L., Park, Soyoung, Persky, Daniel O., Rimsza, Lisa M., Puvvada, Soham D., Schatz, Jonathan H.
الحاوية / القاعدة Leukemia (2015)

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies

بواسطة Kittai, Adam S., Best, Scott, Thurlow, Bria, Lam, Vi, Hashiguchi, Taylor, Goodyear, Shaun, Persky, Daniel O., Okada, Craig, Park, Byung, Spurgeon, Stephen E., Danilov, Alexey V.
الحاوية / القاعدة Haematologica (2021)

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results o...

بواسطة Puvvada, Soham D., Guillén-Rodríguez, José M., Yan, Jessica, Inclán, Lora, Heard, Kara, Rivera, Xavier I., Anwer, Faiz, Mahadevan, Daruka, Schatz, Jonathan H., Persky, Daniel O.
الحاوية / القاعدة Oncology (2018)

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemother...

بواسطة Persky, Daniel O., Dornan, David, Goldman, Bryan H., Braziel, Rita M., Fisher, Richard I., LeBlanc, Michael, Maloney, David G., Press, Oliver W., Miller, Thomas P., Rimsza, Lisa M.
منشور في 2012

Reply to “Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story?” Haematologica. 2012;97(11):e45

بواسطة Persky, Daniel O., Dornan, David, Goldman, Bryan H., Braziel, Rita M., Fisher, Richard I., LeBlanc, Michael, Maloney, David G., Press, Oliver W., Miller, Thomas P., Rimsza, Lisa M.
منشور في 2012

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

بواسطة Matasar, Matthew J., Luminari, Stefano, Barr, Paul M., Barta, Stefan K., Danilov, Alexey V., Hill, Brian T., Phillips, Tycel J., Jerkeman, Mats, Magagnoli, Massimo, Nastoupil, Loretta J., Persky, Daniel O., Okosun, Jessica
الحاوية / القاعدة Oncologist (2019)

A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806

بواسطة Persky, Daniel O., Li, Hongli, Rimsza, Lisa M., Barr, Paul M., Popplewell, Leslie L., Bane, Charles L., Von Gehr, Ann, LeBlanc, Michael, Fisher, Richard I., Smith, Sonali M., Friedberg, Jonathan W.
الحاوية / القاعدة Am J Hematol (2018)

R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study

بواسطة Barr, Paul M, Li, Hongli, Burack, W Richard, LeBlanc, Michael, Smith, Sonali M, Gopal, Ajay K, Floyd, Justin D, Persky, Daniel O, Press, Oliver W, Fisher, Richard I, Friedberg, Jonathan W
الحاوية / القاعدة Lancet Haematol (2018)

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

بواسطة Stasik, Christopher J., Nitta, Hiroaki, Zhang, Wenjun, Mosher, Charles H., Cook, James R., Tubbs, Raymond R., Unger, Joseph M., Brooks, Tracy A., Persky, Daniel O., Wilkinson, Sarah T., Grogan, Thomas M., Rimsza, Lisa M.
منشور في 2010

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

بواسطة Rimsza, Lisa M., Li, Hongli, Braziel, Rita M., Spier, Catherine M., Persky, Daniel O., Dunlap, Jennifer, LeBlanc, Michael, Bartlett, Nancy, Leonard, John P., Smith, Sonali M., Press, Oliver W., Friedberg, Jonathan W.
الحاوية / القاعدة Haematologica (2018)

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

بواسطة Persky, Daniel O., Miller, Thomas P., Unger, Joseph M., Spier, Catherine M., Puvvada, Soham, Stea, B. Dino, Press, Oliver W., Constine, Louis S., Barton, Kevin P., Friedberg, Jonathan W., LeBlanc, Michael, Fisher, Richard I.
الحاوية / القاعدة Blood (2015)